Alcoholic Hepatitis - Pipeline Review, H1 2018

Publisher Name :
Date: 13-Mar-2018
No. of pages: 69
Inquire Before Buying

Alcoholic Hepatitis - Pipeline Review, H1 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcoholic Hepatitis - Pipeline Review, H1 2018, provides an overview of the Alcoholic Hepatitis (Gastrointestinal) pipeline landscape.

Alcoholic hepatitis is an inflammation of the liver. It is typically caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mouth, weight loss, yellowing of the skin or eyes (jaundice), fever and fatigue. Risk factors include alcohol use, obesity and genetic factors. Treatment includes corticosteroids and liver transplant.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alcoholic Hepatitis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Alcoholic Hepatitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 6, 3 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Alcoholic Hepatitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alcoholic Hepatitis (Gastrointestinal).

- The pipeline guide reviews pipeline therapeutics for Alcoholic Hepatitis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Alcoholic Hepatitis (Gastrointestinal) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Alcoholic Hepatitis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Alcoholic Hepatitis (Gastrointestinal)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Alcoholic Hepatitis (Gastrointestinal).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Alcoholic Hepatitis (Gastrointestinal) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Alcoholic Hepatitis - Pipeline Review, H1 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Alcoholic Hepatitis - Overview
Alcoholic Hepatitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Alcoholic Hepatitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Alcoholic Hepatitis - Companies Involved in Therapeutics Development
DURECT Corp
Generon (Shanghai) Corp Ltd
Gilead Sciences Inc
GRI Bio Inc
Immuron Ltd
Intercept Pharmaceuticals Inc
Promethera Biosciences SA
Verlyx Pharma Inc
Vital Therapies Inc
Alcoholic Hepatitis - Drug Profiles
AF-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cell Therapy for Liver Failure and Alcoholic Hepatitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DUR-928 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
F-652 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GRI-0621 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HepaStem - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IMM-124E - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
obeticholic acid - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Oligonucleotide to Inhibit miRNA-155 for Alcoholic Liver Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pentamidine isethionate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PMKM-02GI1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
selonsertib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VB-4A32 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Alcoholic Hepatitis - Dormant Projects
Alcoholic Hepatitis - Product Development Milestones
Featured News & Press Releases
Jun 05, 2017: Vital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis
May 23, 2016: Vital Therapies Enrolls First Subject in VTL-308
Nov 23, 2015: Generon Collaborating with Mayo Clinic to Initiate a Phase IIa Study with F-652, a First-in-Class Biologic, to Treat Patients with Alcoholic Hepatitis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Alcoholic Hepatitis, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Alcoholic Hepatitis - Pipeline by DURECT Corp, H1 2018
Alcoholic Hepatitis - Pipeline by Generon (Shanghai) Corp Ltd, H1 2018
Alcoholic Hepatitis - Pipeline by Gilead Sciences Inc, H1 2018
Alcoholic Hepatitis - Pipeline by GRI Bio Inc, H1 2018
Alcoholic Hepatitis - Pipeline by Immuron Ltd, H1 2018
Alcoholic Hepatitis - Pipeline by Intercept Pharmaceuticals Inc, H1 2018
Alcoholic Hepatitis - Pipeline by Promethera Biosciences SA, H1 2018
Alcoholic Hepatitis - Pipeline by Verlyx Pharma Inc, H1 2018
Alcoholic Hepatitis - Pipeline by Vital Therapies Inc, H1 2018
Alcoholic Hepatitis - Dormant Projects, H1 2018

List of Figures
Number of Products under Development for Alcoholic Hepatitis, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products by Targets, H1 2018
Number of Products by Stage and Targets, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
  • Global Giant Knotweed Rhizome Extract Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Giant Knotweed Rhizome is root of popularly known herb Japanese knotweed. Giant knotweed is a banned herb and declared harmful as it grows anywhere and it's very difficult to get rid of as it has giant roots which can grow in concretes, buildings under any floor etc. Giant knotweed rhizome extract possess high market demand from pharmaceutical as well as herbal and Ayurveda medicine market segments due to its versatile properties. Giant knotweed rhizome extract is rich source of resveratr......
  • Global Eugenia Jambolana Extract Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Eugenia jambsolana offers berry-like fruits that are consumed raw or even cooked. The seeds as well as the bark of Eugenia jambolana are preferred for its therapeutic advantages it offers. Eugenia jambolana is a rich source of vitamin A and vitamin C and also acts as an amazing antioxidant agent for the human cell. The demand for eugenia jambolana extract is also more as it is used as an insecticide in the agricultural field. Among these segment Asia Pacific is expected to hold th......
  • Global Chronic Fatigue Syndrome Treatment Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Chronic fatigue syndrome is not a simple problem for any individual, it's a complex disorder which is considered as thrilling fatigue, which cannot be able to explain by medical conditions. Chronic fatigue syndrome which can prime to deterioration of creatively suffering and harm of quality of life, happiness and mental peace. Chronic fatigue is also known as myalgic encephalomyelitis or encephalopathy which is a complex debilitating disorder, which can affect human normal life style. The cause ......
  • Global Cassia Essential Oil Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Cassia Essential Oil derived by steam distillation of the Cassia plant's bark, leaves and twigs. Cassia is commonly known as Chinese Cinnamon and its scientific name is Cinnamomum Cassia. Cassia is an evergreen tree native to China and Burma. Cassia Essential oil usually consist of benzaldehyde, chavicol, cinnamic aldehyde, cinnamyl acetate, and linalool. Cassia Essential Oil has wide range of application in healthcare industry. Cassia Essential Oil is famously known for improving circulation, t......
  • Global Carb Blocker Supplements Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Carb blocker is a type of dietary supplement which work differently than other weight loss medicines, formulated with various ingredients such as white kidney bean, and green tea extract. Carb blocker is also known as starch blockers which helps in minimizing the alteration of starch into sugar to delay the digestion and absorption of carbohydrates. Some carb blockers are sold as weight loss supplements made from a set of compounds namely alpha-amylase inhibitors, which arise probably in certain......
  • Global Softgel Dietary Supplements Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Available in the form of softgel delivery-systems, dietary supplements like vitamins and minerals, are taking in additional to the normal diet—in high dose and concentration. The dietary supplements could ether be made from plants or be an animal product like fish oil. Tablet formulations, have long dominated the pharmaceutical landscape limited innovations. The trend was reversed with softgel as a popular dosage form among patients. Increasing deviation from raw materials-tasting outer l......
  • Global Two-piece Empty Hard Capsule Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Two-piece empty hard capsules are a dosage format created by pharmaceutical companies to ensure the consumption of medicines. This is beneficial for consumers unable to intake medicines or drugs in tablet form. Raw materials utilized in the production of these capsules include starch & pullulan, gelatin, and hydroxypropyl methylcellulose (HPMC). The gelatin segment can accrue maximum revenue for the two-piece empty hard capsule market in the coming years owing to its protein-dense content......
  • Global Keratin Tablets Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Keratin is one of a family of fibrous structural proteins. Keratin is the protein that protects epithelial cells from damage or stress. The global Keratin Tablets market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Keratin Tablets volume and value at global level, regional level and company level. From a global perspective, this report represents overall Keratin Table......
  • Global Binge Eating Disorder Drug Market Professional Survey Report 2019
    Published: 20-Sep-2019        Price: US 3500 Onwards        Pages: 109
    Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral w......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs